Geometry and fluxes of SL(5) exceptional field theory

We use a geometric approach to construct a flux formulation for the SL(5) U-duality manifest exceptional field theory. The resulting formalism is well-suited for studying gauged supergravities with geometric and non-geometric fluxes. Here we describe all such fluxes for both M-theory and IIB supergravity including the Ramond-Ramond fields for compactifications to seven dimensions. We define the locally non-geometric "R-flux" and globally non-geometric "Q-flux" for M-theory and find a new locally non-geometric R-flux for the IIB theory. We show how these non-geometric fluxes can be understood geometrically and give some examples of how they fluxes can be generated by acting with dualities on solutions with geometric or field-strength flux.Comment: 50 pages; v2: Journal version, minor typos corrected, references adde

The OD,D geometry of string theory

We construct an action for double field theory using a metric connection that is compatible with both the generalised metric and the O_{D,D} structure. The connection is simultaneously torsionful and flat. Using this connection one may construct a proper covariant derivative for double field theory. We then write the doubled action in terms of the generalised torsion of this connection. This action then exactly reproduces that required for doubled field theory and gauged supergravity.Comment: 26 pages, latex, v2 typos corrected and references adde

Heroesx: The Ancient Greek Hero: Spring 2013 Course Report

CB22x: The Ancient Greek Hero, was offered as a HarvardX course in Spring 2013 on edX, a platform for massive open online courses (MOOCs). It was taught by Professor Greg Nagy. The report was prepared by researchers external to the course team, based on examination of the courseware, analyses of the data collected by the edX platform, and interviews and consultations with the course faculty and team members

Tropical-cyclone-driven erosion of the terrestrial biosphere from mountains

The transfer of organic carbon from the terrestrial biosphere to the oceans via erosion and riverine transport constitutes an important component of the global carbon cycle. More than one third of this organic carbon flux comes from sediment-laden rivers that drain the mountains in the western Pacific region. This region is prone to tropical cyclones, but their role in sourcing and transferring vegetation and soil is not well constrained. Here we measure particulate organic carbon load and composition in the LiWu River, Taiwan, during cyclone-triggered floods. We correct for fossil particulate organic carbon using radiocarbon, and find that the concentration of particulate organic carbon from vegetation and soils is positively correlated with water discharge. Floods have been shown to carry large amounts of clastic sediment. Non-fossil particulate organic carbon transported at the same time may be buried offshore under high rates of sediment accumulation. We estimate that on decadal timescales, 77–92% of non-fossil particulate organic carbon eroded from the LiWu catchment is transported during large, cyclone-induced floods. We suggest that tropical cyclones, which affect many forested mountains within the Intertropical Convergence Zone, may provide optimum conditions for the delivery and burial of non-fossil particulate organic carbon in the ocean. This carbon transfer is moderated by the frequency, intensity and duration of tropical cyclones

An action for F-theory: SL(2)R+ exceptional field theory

DSB is supported by the STFC grant ST/L000415/1 'String Theory, Gauge Theory and Duality'. CB is supported in part by the Belgian Federal Science Policy Office through the Interuniversity Attraction Pole P7/37 'Fundamental Interactions', and in part by the 'FWO-Vlaanderen' through the project G.0207.14N and by the Vrije Universiteit Brussel through the Strategic Research Program 'High-Energy Physics'. EM is supported by the ERC Advanced Grant "Strings and Gravity' (Grant No. 32004). FJR is supported by an STFC studentship

A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research.

The origins of the major classes of current anti-emetics are examined. Serendipity is a recurrent theme in discovery of their anti-emetic properties and repurposing from one indication to another is a continuing trend. Notably, the discoveries have occurred against a background of company mergers and changing anti-emetic requirements. Major drug classes include: (i) Muscarinic receptor antagonists-originated from historical accounts of plant extracts containing atropine and hyoscine with development stimulated by the need to prevent sea-sickness among soldiers during beach landings; (ii) Histamine receptor antagonists-searching for replacements for the anti-malaria drug quinine, in short supply because of wartime shipping blockade, facilitated the discovery of histamine (H1) antagonists (e.g., dimenhydrinate), followed by serendipitous discovery of anti-emetic activity against motion sickness in a patient undergoing treatment for urticaria; (iii) Phenothiazines and dopamine receptor antagonists-investigations of their pharmacology as "sedatives" (e.g., chlorpromazine) implicated dopamine receptors in emesis, leading to development of selective dopamine (D2) receptor antagonists (e.g., domperidone with poor ability to penetrate the blood-brain barrier) as anti-emetics in chemotherapy and surgery; (iv) Metoclopramide and selective 5-hydroxytryptamine3(5-HT3) receptor antagonists-metoclopramide was initially assumed to act only via D2 receptor antagonism but subsequently its gastric motility stimulant effect (proposed to contribute to the anti-emetic action) was shown to be due to 5-hydroxytryptamine4 receptor agonism. Pre-clinical studies showed that anti-emetic efficacy against the newly-introduced, highly emetic, chemotherapeutic agent cisplatin was due to antagonism at 5-HT3 receptors. The latter led to identification of selective 5-HT3 receptor antagonists (e.g., granisetron), a major breakthrough in treatment of chemotherapy-induced emesis; (v) Neurokinin1receptor antagonists-antagonists of the actions of substance P were developed as analgesics but pre-clinical studies identified broad-spectrum anti-emetic effects; clinical studies showed particular efficacy in the delayed phase of chemotherapy-induced emesis. Finally, the repurposing of different drugs for treatment of nausea and vomiting is examined, particularly during palliative care, and also the challenges in identifying novel anti-emetic drugs, particularly for treatment of nausea as compared to vomiting. We consider the lessons from the past for the future and ask why there has not been a major breakthrough in the last 20 years